Product category:
Polymerase chain reaction (PCR)
News Release from: Qiagen
Edited by the Laboratorytalk Editorial
Team on 31 March 2008
Susan Lindquist wins the Otto Warburg
medal
The medal is considered the most prestigious German award for biochemists and molecular biologists, is awarded by the German Association of Biochemistry and Molecular Biology and sponsored by Qiagen
American scientist Susan Lindquist was awarded the Otto Warburg Medal in Mosbach, Germany Seven recipients of the Otto Warburg Medal have subsequently received the Nobel Prize
This article was originally published on Laboratorytalk on 20 Aug 2001 at 8.00am (UK)
Related stories
Bulk recombinant enzymes
The efficient and highly specific removal of His tags offered by the TagZyme system makes it the ideal choice for the generation of proteins free from vector-encoded amino acids
A hot concept for high-fidelity PCR
Qiagen introduces ProofStart DNA polymerase, a new proofreading enzyme for robust, high-fidelity PCR promising extremely low error rates Proofreading enzymes utili
This year's prize was sponsored by Qiagen.
Lindquist is member of the Whitehead Institute, professor of biology at the Massachusetts Institute of Technology (MIT) and investigator at the Howard Hughes Medical Institute.
The award recognised her research into the field of protein folding, allowing a greater understanding of serious diseases like Parkinson's.
Further reading
Robotic handling for the bio lab
Qiagen's collaboration with Zymark has led to the development of an automated rapid handling solution for 96- and 384-well formats - the BioRobot RapidPlate
New adjuvant technology for mice
Qiagen introduces ImmunEasy Mouse Adjuvant, a new type of adjuvant provided as a ready-to-use aqueous suspension, specifically designed to induce high antibody titers in mice
"I am very proud to receive the Otto Warburg Medal of the GBM.
I also appreciate Qiagen's commitment to furthering research in biochemistry and molecular biology by sponsoring this prize," said Lindquist.
Proteins are essential components of all organisms and participate in every process within cells.
Susan Lindquist has dedicated her research to these biomolecules, particularly to how they manage to build their shape - a process called protein folding.
One of her important findings is that a dysfunction in the folding of the molecules' three-dimensional structure can have profound influence on the development of human diseases such as Alzheimer's and Parkinson's.
Lindquist and colleagues have developed yeast strains that serve as living test tubes in which these disorders can be studied, revealing the role of protein folding.
For instance, she has succeeded in reproducing many of the biological consequences of Parkinson's in yeast cells and her team is screening for drugs to prevent and treat the disease.
Lindquist's wide-ranging investigations in protein folding also have included prions - the so-called small proteinaceous infectious particles.
Prions are proteins that can change into a self-perpetuating infective form.
They have become well-known in the last decades as the cause of the mad cow and Creutzfeldt-Jakob disease.
Lindquist investigated how prions form and then trigger these diseases.
"Susan Lindquist's findings in the field of protein folding are groundbreaking," said Alfred Wittinghofer, president of the GBM.
"It is only because of her outstanding research that we understand today many human and animal diseases such as mad cow disease.
"If one day these severe diseases can be cured, Susan's research will have been a crucial contributing factor".
Birgit Jostes, senior global director corporate marketing and strategy at Qiagen, said: "It is an honor for us to be able to contribute to the success of internationally recognised scientists through the sponsorship of the Otto Warburg Medal.
"Through our innovative sampling and testing technologies, it is Qiagen's mission to contribute to the success of our customers as they pioneer discoveries such as Susan Lindquist's.
"Those findings serve as the basis for the development of effective therapies against most challenging diseases.".
• Qiagen: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
